Dr. Mark Sulkowski and Dr. Kathleen Brady discuss the struggle between addiction and HCV. Appropriate treatment begins with screening and diagnosis, overcoming barriers to treatment and adherence, and collaboration between caregivers. And for the first time, experts in HCV confidently use the word “cure” to describe the achievable endpoint of treatment. Dr. Sulkowski begins by introducing a young woman named Theresa who struggled with addiction to opioids. Listen as they are joined by Dr. Alain Litwin, who describes barriers and the epidemiology of HCV infection in the US.Post-Test
Dr. Mark Sulkowski and Dr. Kathleen Brady discuss the game-changing treatments that are now available to cure HCV, and strategies to apply these treatments in the addiction medicine setting. Listen as they are joined by Dr. Raymond Chung, who discusses guidelines and new combination regimens.Post-Test
Supported by an independant educational grant from Gilead Sciences Inc.
Hepatitis C (HCV) is the most-deadly infectious disease in America.
HCV is curable, even among past and current drug users. You can help turn the tide. Learn how to screen (hint: it's easy) and how screening can save lives.
Treatment is now simpler, more effective, and shorter than ever. And it should be offered to nearly everyone with HCV, regardless of the level of cirrhosis.
Tune in to START HCV Radio Hour to listen and learn as our expert faculty explore important topics, using patient stories in an engaging moderated DKBmed Talk, modeled after the famous and popular TED Talks.
The expert faculty includes Mark Sulkowski, MD, professor of medicine and medical director of the Viral Hepatitis Center at the Johns Hopkins University School of Medicine; Alain Litwin, MD, professor of medicine at Albert Einstein College of Medicine in New York; Kathleen Brady, MD, Distinguished University Professor at the Medical University of South Carolina and Director of the South Carolina Clinical and Translational Research Institute; and Raymond Chung, MD, director of hepatology and the Liver Center at Massachusetts General Hospital in Boston.Start Program
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
Johns Hopkins University School of Medicine
Kathleen T. Brady, MD, PhD
Distinguished University Professor
Vice President for Research
Director, South Carolina Clinical and Translational Research Institute
Medical University of South Carolina
Charleston, South Carolina
Alain H. Litwin, MD
Professor, Department of Medicine (General Internal Medicine)
Department of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Montefiore Medical Center
Raymond T. Chung, MD
Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Harvard Medical School
This activity has been designed to meet the educational needs of clinicians interested in addiction medicine.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBmed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates these enduring activities for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Part 1: This program was approved for .5 General contact hour(s) of continuing education credit by the National Association of Social Workers—Louisiana Chapter as authorized by the Louisiana State Board of Social Work Examiners.
Part 2: This program was approved for .5 General contact hour(s) of continuing education credit by the National Association of Social Workers—Louisiana Chapter as authorized by the Louisiana State Board of Social Work Examiners.
Estimated time to complete each activity: 0.5 hours (1.0 hours total)
After completing this activity, the participant should be better able to:
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following DKB planners and managers Stan Pogroszewski, and Rachel Deerr hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participation in this CME activity. To receive credit, participants must 1) read the learning objectives and disclosure statements, 2) complete the educational activity and 3) complete the post-test and activity evaluation form, including the certificate information section. Physicians and social workers must attest to the amount of time they spent on the activity.
PC: Internet Explorer (v9 or greater), Chrome or Firefox
Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.